Agios Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical
Founded
2008
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Agios Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $86.9B in funding across 112 round(s). With a team of 101-250 employees, Agios Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Funding Round - Agios Pharmaceuticals, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
0
Lead Investors
0
Total Funding Amount
$775.8M
Details
3
Agios Pharmaceuticals has raised a total of $775.8M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2008 | Early Stage Venture | 33.0M | ||
| 2010 | Early Stage Venture | 8.8M | ||
| 2011 | Late Stage Venture | 78.0M |
Investors
Agios Pharmaceuticals is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ARCH Venture Partners | - | FUNDING ROUND - ARCH Venture Partners | 33.0M |
| Perry Karsen | - | FUNDING ROUND - Perry Karsen | 8.8M |
| Agios Pharmaceuticals | - | FUNDING ROUND - Agios Pharmaceuticals | 8.8M |
| Celgene | - | FUNDING ROUND - Celgene | 8.8M |
Recent Activity
There is no recent news or activity for this profile.